Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
Identifieur interne : 001014 ( Main/Corpus ); précédent : 001013; suivant : 001015Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
Auteurs : Jeffrey Francer ; Jose Zamarriego Izquierdo ; Tamara Music ; Kirti Narsai ; Chrisoula Nikidis ; Heather Simmonds ; Paul WoodsSource :
- Philosophy, ethics, and humanities in medicine : PEHM [ 1747-5341 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical : Prescription Drugs.
- ethics : Drug Industry, Marketing.
- legislation & jurisprudence : Drug Industry, Marketing.
- Communication, Humans, Internationality, Social Control, Informal.
Abstract
The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyzes legislative, regulatory, and code-based compliance control mechanisms and highlights significant developments, including the 2006 and 2012 revisions of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice.Developments in international controls, largely built upon long-established rules relating to the quality of advertising material, have contributed to clarifying the scope of acceptable company interactions with healthcare professionals. This article aims to provide policy makers, particularly in developing countries, with an overview of the evolution of mechanisms governing the communication practices, such as the distribution of promotional or scientific material and interactions with healthcare stakeholders, relating to prescription-only medicines.
DOI: 10.1186/1747-5341-9-7
PubMed: 24679064
PubMed Central: PMC3974225
Links to Exploration step
pubmed:24679064Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ethical pharmaceutical promotion and communications worldwide: codes and regulations.</title><author><name sortKey="Francer, Jeffrey" sort="Francer, Jeffrey" uniqKey="Francer J" first="Jeffrey" last="Francer">Jeffrey Francer</name></author><author><name sortKey="Izquierdo, Jose Zamarriego" sort="Izquierdo, Jose Zamarriego" uniqKey="Izquierdo J" first="Jose Zamarriego" last="Izquierdo">Jose Zamarriego Izquierdo</name></author><author><name sortKey="Music, Tamara" sort="Music, Tamara" uniqKey="Music T" first="Tamara" last="Music">Tamara Music</name></author><author><name sortKey="Narsai, Kirti" sort="Narsai, Kirti" uniqKey="Narsai K" first="Kirti" last="Narsai">Kirti Narsai</name></author><author><name sortKey="Nikidis, Chrisoula" sort="Nikidis, Chrisoula" uniqKey="Nikidis C" first="Chrisoula" last="Nikidis">Chrisoula Nikidis</name></author><author><name sortKey="Simmonds, Heather" sort="Simmonds, Heather" uniqKey="Simmonds H" first="Heather" last="Simmonds">Heather Simmonds</name></author><author><name sortKey="Woods, Paul" sort="Woods, Paul" uniqKey="Woods P" first="Paul" last="Woods">Paul Woods</name><affiliation><nlm:affiliation>Paul Woods Compliance Ltd, Macclesfield, UK. pwcompliance@btinternet.com.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24679064</idno><idno type="pmid">24679064</idno><idno type="doi">10.1186/1747-5341-9-7</idno><idno type="pmc">PMC3974225</idno><idno type="wicri:Area/Main/Corpus">001014</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001014</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Ethical pharmaceutical promotion and communications worldwide: codes and regulations.</title><author><name sortKey="Francer, Jeffrey" sort="Francer, Jeffrey" uniqKey="Francer J" first="Jeffrey" last="Francer">Jeffrey Francer</name></author><author><name sortKey="Izquierdo, Jose Zamarriego" sort="Izquierdo, Jose Zamarriego" uniqKey="Izquierdo J" first="Jose Zamarriego" last="Izquierdo">Jose Zamarriego Izquierdo</name></author><author><name sortKey="Music, Tamara" sort="Music, Tamara" uniqKey="Music T" first="Tamara" last="Music">Tamara Music</name></author><author><name sortKey="Narsai, Kirti" sort="Narsai, Kirti" uniqKey="Narsai K" first="Kirti" last="Narsai">Kirti Narsai</name></author><author><name sortKey="Nikidis, Chrisoula" sort="Nikidis, Chrisoula" uniqKey="Nikidis C" first="Chrisoula" last="Nikidis">Chrisoula Nikidis</name></author><author><name sortKey="Simmonds, Heather" sort="Simmonds, Heather" uniqKey="Simmonds H" first="Heather" last="Simmonds">Heather Simmonds</name></author><author><name sortKey="Woods, Paul" sort="Woods, Paul" uniqKey="Woods P" first="Paul" last="Woods">Paul Woods</name><affiliation><nlm:affiliation>Paul Woods Compliance Ltd, Macclesfield, UK. pwcompliance@btinternet.com.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Philosophy, ethics, and humanities in medicine : PEHM</title><idno type="eISSN">1747-5341</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communication (MeSH)</term><term>Drug Industry (ethics)</term><term>Drug Industry (legislation & jurisprudence)</term><term>Humans (MeSH)</term><term>Internationality (MeSH)</term><term>Marketing (ethics)</term><term>Marketing (legislation & jurisprudence)</term><term>Prescription Drugs (MeSH)</term><term>Social Control, Informal (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Prescription Drugs</term></keywords><keywords scheme="MESH" qualifier="ethics" xml:lang="en"><term>Drug Industry</term><term>Marketing</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Drug Industry</term><term>Marketing</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Communication</term><term>Humans</term><term>Internationality</term><term>Social Control, Informal</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyzes legislative, regulatory, and code-based compliance control mechanisms and highlights significant developments, including the 2006 and 2012 revisions of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice.Developments in international controls, largely built upon long-established rules relating to the quality of advertising material, have contributed to clarifying the scope of acceptable company interactions with healthcare professionals. This article aims to provide policy makers, particularly in developing countries, with an overview of the evolution of mechanisms governing the communication practices, such as the distribution of promotional or scientific material and interactions with healthcare stakeholders, relating to prescription-only medicines. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24679064</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2014</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1747-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Philosophy, ethics, and humanities in medicine : PEHM</Title><ISOAbbreviation>Philos Ethics Humanit Med</ISOAbbreviation></Journal><ArticleTitle>Ethical pharmaceutical promotion and communications worldwide: codes and regulations.</ArticleTitle><Pagination><MedlinePgn>7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1747-5341-9-7</ELocationID><Abstract><AbstractText>The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyzes legislative, regulatory, and code-based compliance control mechanisms and highlights significant developments, including the 2006 and 2012 revisions of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice.Developments in international controls, largely built upon long-established rules relating to the quality of advertising material, have contributed to clarifying the scope of acceptable company interactions with healthcare professionals. This article aims to provide policy makers, particularly in developing countries, with an overview of the evolution of mechanisms governing the communication practices, such as the distribution of promotional or scientific material and interactions with healthcare stakeholders, relating to prescription-only medicines. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Francer</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Jose Zamarriego</ForeName><Initials>JZ</Initials></Author><Author ValidYN="Y"><LastName>Music</LastName><ForeName>Tamara</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Narsai</LastName><ForeName>Kirti</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nikidis</LastName><ForeName>Chrisoula</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Simmonds</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Paul Woods Compliance Ltd, Macclesfield, UK. pwcompliance@btinternet.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Philos Ethics Humanit Med</MedlineTA><NlmUniqueID>101258058</NlmUniqueID><ISSNLinking>1747-5341</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055553">Prescription Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="Y">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName><QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038622" MajorTopicYN="N">Internationality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040541" MajorTopicYN="N">Marketing</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName><QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055553" MajorTopicYN="N">Prescription Drugs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012927" MajorTopicYN="N">Social Control, Informal</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24679064</ArticleId><ArticleId IdType="pii">1747-5341-9-7</ArticleId><ArticleId IdType="doi">10.1186/1747-5341-9-7</ArticleId><ArticleId IdType="pmc">PMC3974225</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001014 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001014 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SanteMusiqueV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:24679064
|texte= Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:24679064" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SanteMusiqueV1
| This area was generated with Dilib version V0.6.38. |  |